214 related articles for article (PubMed ID: 19160137)
1. Induction of rejection after small-for-size liver transplantation: size matters.
Dirsch O; Li J; He Q; Ji Y; Gu YL; Dahmen U
J Invest Surg; 2008; 21(5):288-98. PubMed ID: 19160137
[TBL] [Abstract][Full Text] [Related]
2. Prolonged cold ischemia does not trigger lethal rejection or accelerate the acute rejection in two allogeneic rat liver transplantation models.
Jin H; Dahmen U; Liu A; Huang H; Gu Y; Dirsch O
J Surg Res; 2012 Jun; 175(2):322-32. PubMed ID: 21612794
[TBL] [Abstract][Full Text] [Related]
3. Optimal immunosuppressor induces stable gut microbiota after liver transplantation.
Jiang JW; Ren ZG; Lu HF; Zhang H; Li A; Cui GY; Jia JJ; Xie HY; Chen XH; He Y; Jiang L; Li LJ
World J Gastroenterol; 2018 Sep; 24(34):3871-3883. PubMed ID: 30228781
[TBL] [Abstract][Full Text] [Related]
4. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
[TBL] [Abstract][Full Text] [Related]
6. Approaching treatment for immunological rejection of living-donor liver transplantation in rats.
Feng Y; Han Z; Feng Z; Wang B; Cheng H; Yang L; Li Y; Gu B; Li X; Li Y; Li Y; Wang C; Chen H
BMC Gastroenterol; 2020 Jan; 20(1):7. PubMed ID: 31931737
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation-mediated transfer of immunity: accelerated rejection of a skin graft from a sensitized donor.
Dahmen U; Tanigawa T; Doebel L; Rogiers X; Lindkaer-Jensen S; Broelsch CE
Transplant Proc; 1997; 29(1-2):1123-5. PubMed ID: 9123228
[No Abstract] [Full Text] [Related]
8. Regeneration-induced accelerated rejection in reduced-size liver grafts.
Shiraishi M; Csete ME; Yasunaga C; Drazan KE; Jurim O; Cramer DV; Busuttil RW; Shaked A
Transplantation; 1994 Feb; 57(3):336-40. PubMed ID: 7509085
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a chronic rejection model for orthotopic liver transplantation in the rat.
Wu YB; Huang QM; Liu JF
Eur Surg Res; 2011; 46(2):94-101. PubMed ID: 21228596
[TBL] [Abstract][Full Text] [Related]
10. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
Knoop M; Cramer DV; Chapman FC; Makowka L
Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
[No Abstract] [Full Text] [Related]
11. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
12. The positive effect of immunosuppression on adaptation of venous allografts to arterialisation in rats.
Matia I; Varga M; Lodererova A; Adamec M
Eur J Vasc Endovasc Surg; 2010 Apr; 39(4):478-84. PubMed ID: 20015668
[TBL] [Abstract][Full Text] [Related]
13. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
Knoop M; Cramer DV; Chapman FC; Makowka L
Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
[No Abstract] [Full Text] [Related]
14. FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation.
Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Kubo S; Takemura S; Ikeda K; Minamiyama Y; Hirohashi K; Suehiro S
Transplantation; 2004 Dec; 78(11):1618-25. PubMed ID: 15591950
[TBL] [Abstract][Full Text] [Related]
15. FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats.
Murase N; Kim DG; Todo S; Cramer DV; Fung J; Starzl TE
Transplantation; 1990 Nov; 50(5):739-44. PubMed ID: 1700504
[TBL] [Abstract][Full Text] [Related]
16. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger protein A20 promotes regeneration of small-for-size liver allograft and suppresses rejection and results in a longer survival in recipient rats.
Xu MQ; Yan LN; Gou XH; Li DH; Huang YC; Hu HY; Wang LY; Han L
J Surg Res; 2009 Mar; 152(1):35-45. PubMed ID: 19027921
[TBL] [Abstract][Full Text] [Related]
18. "Tolerogenic effect" of the liver for a small bowel allograft.
Meyer D; Otto C; Rummel C; Gassel HJ; Timmermann W; Ulrichs K; Thiede A
Transpl Int; 2000; 13 Suppl 1():S123-6. PubMed ID: 11111977
[TBL] [Abstract][Full Text] [Related]
19. Augmenter of liver regeneration attenuates acute rejection after rat liver transplantation.
Chen Y; Liang S; Long F; Li J; Gong J
Am J Surg; 2016 Jul; 212(1):128-37. PubMed ID: 27041247
[TBL] [Abstract][Full Text] [Related]
20. Accelerated rejection of a skin graft after liver transplantation from a sensitized donor: functional aspects of microchimerism.
Dahmen U; Tanigawa T; Rogiers X; Lindkaer-Jensen S; Broelsch CE
Transplant Proc; 1996 Dec; 28(6):3243-5. PubMed ID: 8962256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
